Michael Craig Miller

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• The utility of the novel biomarker HE4 for monitoring epithelial ovarian cancer during PARP inhibitor treatment

  International Journal of Gynecological Cancer · 2025-09-27 · 1 citations

• Identification of circulating tumor cells captured by the FDA-cleared Parsortix® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations

  Journal of Experimental & Clinical Cancer Research · 2024-08-21 · 16 citations